Article info

Download PDFPDF

A TIGIT-based chimeric co-stimulatory switch receptor improves T-cell anti-tumor function

Authors

  • Shiran Hoogi The Laboratory of Tumor Immunology and Immunotherapy, The Mina and Everard Goodman Faculty of Life SciencesBar-Ilan University 52900-02 Ramat Gan Israel PubMed articlesGoogle scholar articles
  • Vasyl Eisenberg The Laboratory of Tumor Immunology and Immunotherapy, The Mina and Everard Goodman Faculty of Life SciencesBar-Ilan University 52900-02 Ramat Gan Israel PubMed articlesGoogle scholar articles
  • Shimrit Mayer The Laboratory of Tumor Immunology and Immunotherapy, The Mina and Everard Goodman Faculty of Life SciencesBar-Ilan University 52900-02 Ramat Gan Israel PubMed articlesGoogle scholar articles
  • Astar Shamul The Laboratory of Tumor Immunology and Immunotherapy, The Mina and Everard Goodman Faculty of Life SciencesBar-Ilan University 52900-02 Ramat Gan Israel PubMed articlesGoogle scholar articles
  • Tilda Barliya The Laboratory of Tumor Immunology and Immunotherapy, The Mina and Everard Goodman Faculty of Life SciencesBar-Ilan University 52900-02 Ramat Gan Israel PubMed articlesGoogle scholar articles
  • Cyrille J. Cohen The Laboratory of Tumor Immunology and Immunotherapy, The Mina and Everard Goodman Faculty of Life SciencesBar-Ilan University 52900-02 Ramat Gan Israel PubMed articlesGoogle scholar articles

Citation

Hoogi S, Eisenberg V, Mayer S, et al
A TIGIT-based chimeric co-stimulatory switch receptor improves T-cell anti-tumor function
Online issue publication 
January 08, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.